We empathize with patients’ pain—and move beyond the limits of treatment through science.
Hello, I am Glenn Lee, CEO of MXBIO, Inc.
Innovation born from unmet needs in clinical practice
In the dental clinic, peri-implantitis has long been one of the most challenging conditions for both clinicians and patients. With limited effective non-surgical options available, we started by asking a fundamental question:
“Why isn’t there a treatment we can truly trust?”
That question became the starting point of MXBIO, Inc.
PERIMEDI®—backed by evidence, proven through clinical data
Developed through years of rigorous research, multi-center clinical studies, and close collaboration with professors and specialists in periodontics and oral and maxillofacial surgery, PERIMEDI® goes beyond a single product. It represents a new paradigm for treating dental and oral diseases.
Today, MXBIO, Inc. is growing into a proprietary biomaterials platform company—one that proposes new approaches to dental and oral care beyond a single solution.
A global challenge, technology for people
Now, MXBIO, Inc. is stepping beyond Korea and into the global market with confidence. By advancing treatment paradigms through technology—and earning trust from both patients and clinicians—we aim to contribute to healthier lives worldwide.
Thank you for your continued interest and support.
Glenn Lee
CEO, MXBIO, Inc.
MXBIO’s science is completed in
patients’ smiles—and
we will answer that journey with trust.
We empathize with patients’ pain—and move beyond the limits of treatment through science.
Hello, I am Glenn Lee, CEO of MXBIO, Inc.
Innovation born from unmet needs in clinical practice
In the dental clinic, peri-implantitis has long been one of the most challenging conditions for both clinicians and patients. With limited effective non-surgical options available, we started by asking a fundamental question:
“Why isn’t there a treatment we can truly trust?”
That question became the starting point of MXBIO, Inc.
PERIMEDI®—backed by evidence, proven through clinical data
Developed through years of rigorous research, multi-center clinical studies, and close collaboration with professors and specialists in periodontics and oral and maxillofacial surgery, PERIMEDI® goes beyond a single product. It represents a new paradigm for treating dental and oral diseases.
Today, MXBIO, Inc. is growing into a proprietary biomaterials platform company—one that proposes new approaches to dental and oral care beyond a single solution.
A global challenge, technology for people
Now, MXBIO, Inc. is stepping beyond Korea and into the global market with confidence. By advancing treatment paradigms through technology—and earning trust from both patients and clinicians—we aim to contribute to healthier lives worldwide.
Thank you for your continued interest and support.
Glenn Lee
CEO, MXBIO, Inc.
MXBIO’s science is completed in patients’ smiles—and we will answer that journey with trust.
